- DB-OTO met week-24 hearing endpoints in 9/12 children.
- Treated ears improved on audiometry and ABR.
- Six heard soft speech; three reached normal hearing levels.
- Some showed speech-perception gains after 48 weeks.
- Adverse events reflected surgical delivery; two serious events resolved.
- Small, open-label study with short primary follow-up.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
